Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 2 (2 total).

Coll C. 1995. Behavioral Intervention with IUGR Infants [Final report]. Wellesely, MA: Women and Infants' Hospital of Rhode Island, 52 pp.

Annotation: The purpose of this 3-year longitudinal intervention study was to: (1) Examine the effectiveness of a parent-infant based behavioral intervention during the neonatal period to prevent or ameliorate the negative consequences of intrauterine growth retardation (IUGR) on maternal-child sensitivity and infant physical growth, caloric intake, cognitive development, and language development; and (2) examine the mediating effects of cultural context and risk status on the effectiveness of intervention with IUGR infants. The planned intervention was expected to affect outcomes directly by improving caloric intake and indirectly by improving mother-infant interactions. [Funded by the Maternal and Child Health Bureau]

Contact: National Technical Information Service, O.S. Department of Commerce, 5301 Shawnee Road, Alexandria, VA 22312, Telephone: (703) 605-6050 Secondary Telephone: (888) 584-8332 E-mail: [email protected] Web Site: http://www.ntis.gov Document Number: NTIS PB96-187281.

Keywords: Bayley Scales of Infant Development, Fetal growth Retardation, Hispanics, Intervention

Yerby M. 1990. Epilepsy in Pregnancy: Developmental Followup of Infants: [Final report]. Seattle, WA: University of Washington, 35 pp.

Annotation: This project studied the effects of epilepsy on pregnancy outcomes. The purpose of the study was to: (1) Examine the outcome of infants exposed in utero to antiepileptic drugs and/or to maternal seizures, and compare their outcome to that of a group of infants without such exposure; and (2) look for correlates in pregnancy (i.e., seizure type and frequency, and antiepileptic drug use) that may predict adverse outcome. A group of pregnant women with epilepsy, a group of nonepileptic pregnant women, and the case and control infants were followed for a period of three years. Case children had a statistically significant higher mean number of minor anomalies per child (5.05) than the control children (3.65). Given the results of the study, with similar rates of malformations with exposure to the common antiepileptic drugs, it was suggested that maternal antiepileptic drugs be chosen for the most effective maternal seizure control. Further research is needed to address the neurodevelopmental effects of these medications. [Funded by the Maternal and Child Health Bureau]

Contact: National Technical Information Service, O.S. Department of Commerce, 5301 Shawnee Road, Alexandria, VA 22312, Telephone: (703) 605-6050 Secondary Telephone: (888) 584-8332 E-mail: [email protected] Web Site: http://www.ntis.gov Document Number: NTIS PB92-135870.

Keywords: Bayley Scales, Birth Defects, Breastfeeding, Child Development, Epilepsy, High risk infants, High risk mothers, High risk pregnancy, Neuromotor Status, Parent-Child Interaction, Pregnant Women, Seizures, Stanford-Binet IV
   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.